C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2002
11/06/2002	CN1377964A China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method
11/06/2002	CN1377963A China bee sedative peptide precursor gene and its coded polypeptide and preparing method
11/06/2002	CN1377893A Interleukin 11 analog
11/06/2002	CN1377891A Zinc finger protein from dendritic cell, its coding sequence and use
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476187 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475983 Water-soluble polypeptides having a high affinity for α and β interferons
11/05/2002	US6475787 Method for producing monoclonal antibodies
11/05/2002	US6475766 Human osteoclast-derived cathepsin
11/05/2002	US6475756 Development of viruses resistant to inactivation by the human complement system
11/05/2002	US6475749 Rh hybrid antibody
11/05/2002	US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002	US6475741 Antiinflammatory agents
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475485 Two novel human cathepsin proteins
11/05/2002	CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002	CA2234396C Method for production of native human leukocyte (alpha) interferon
11/05/2002	CA2147124C Erythropoietin analogs
11/05/2002	CA2091449C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/05/2002	CA2066777C Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
11/05/2002	CA2037779C Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
11/05/2002	CA2011833C Novel polypeptide and production thereof
11/03/2002	CA2384605A1 Granule-bound starch synthase
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086096A2 Methods of producing or identifying intrabodies in eukaryotic cells
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086089A2 The 76a11 polypeptide and uses thereof
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086079A2 T1r3 a novel taste receptor
10/31/2002	WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086059A2 Recombinant vaccinia viral vectors
10/31/2002	WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085941A2 Modified interferon alpha with reduced immunogenicity
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085936A1 Mutants of green fluorescent protein
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085924A2 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE
10/31/2002	WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002	WO2002085840A1 Process for producing n-formylamino acid and utilization thereof
10/31/2002	WO2002085416A1 Viral vectors having reduced virulence
10/31/2002	WO2002085310A2 Antibiotics aa-896
10/31/2002	WO2002085302A2 Methods of treating intestinal inflammation
10/31/2002	WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002	WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002040652A3 Novel soluble endoproteases for the in vitro processing of recombinant proteins
10/31/2002	WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002	WO2002031137A3 Cytomegalovirus intron a fragments
10/31/2002	WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002	WO2002014499A3 Claudin polypeptides
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002	WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002	WO2001060156A9 Neutralizing antibody and immunomodulatory enhancing compositions
10/31/2002	US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002	US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002	US20020161208 Useful for diagnosing, therapy, prophylaxis and/or prognosing disorders related to these novel polypeptides
10/31/2002	US20020161202 For modulating apoptosis in mammalian cells
10/31/2002	US20020161201 For use in cancer diagnosis and therapy
10/31/2002	US20020161200 For therapy
10/31/2002	US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002	US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002	US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002	US20020161191 Novel Imidazoline receptor homologs
10/31/2002	US20020161190 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability
10/31/2002	US20020161178 Novel DKR polypeptides
10/31/2002	US20020160971 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor
10/31/2002	US20020160957 Treating tumors
10/31/2002	US20020160940 Modulation of endogenous gene expression in cells
10/31/2002	US20020160494 Tendon-inducing compositions
10/31/2002	US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002	US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002	US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002	US20020160477 CAF1-related protein
10/31/2002	US20020160473 Far red shifted fluorescent proteins
10/31/2002	US20020160472 Coupling drug to glycidyl methacrylate-styrene copolymer
10/31/2002	US20020160463 Phagemid for antibody screening
10/31/2002	US20020160460 Practical in vitro sialylation of recombinant glycoproteins
10/31/2002	US20020160458 Gene expression of endoprotease in eukaryotic cells; yeast culture product
10/31/2002	US20020160455 Methods and host cells for improved cell culture
10/31/2002	US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002	US20020160432 Quantitative analysis; diagnosis of infections
10/31/2002	US20020160425 Process for differential diagnosis of Alzheimer's dementia and device therefor
10/31/2002	US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002	US20020160384 Polypeptides; binding to antibodies
10/31/2002	US20020160374 Fusion protein; genetic engineering; binding to antibodies

1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 1125